Tenaya Therapeutics News

Latest Tenaya Therapeutics Stock News & TNYA Headlines

Tenaya Therapeutics, Inc. (TNYA) Reports Q3 Loss, Beats Revenue Estimates

11 days ago | zacks.com

Tenaya Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update

11 days ago | globenewswire.com

Tenaya Therapeutics (NASDAQ:TNYA) and C4 Therapeutics (NASDAQ:CCCC) Financial Survey

24 days ago | defenseworld.net

Tenaya Therapeutics, Inc. (TNYA) Presents at H.C. Wainwright 28th Annual Global Investment Conference Transcript

2 months ago | seekingalpha.com

Tenaya Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy

2 months ago | globenewswire.com

Tenaya Therapeutics to Participate in Upcoming September Investor Conferences

2 months ago | globenewswire.com

Tenaya Therapeutics Eyes Q4 Updates for Cardiac Gene Therapies, TN-301

3 months ago | marketbeat.com

Tenaya Therapeutics, Inc. (TNYA) Presents at Canaccord Genuity's 46th Annual Growth Conference Transcript

3 months ago | seekingalpha.com

Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

3 months ago | globenewswire.com

Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

4 months ago | globenewswire.com

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

Market Closed

TNYA

Tenaya Therapeutics

$ 0.3492

0.49%

Last 24H

Trading with leverage comes with a high risk and may not be suitable for everyone.

Portfolio

Updated 2 days ago

Top

Gainers

Losers

Symbol

Last Price

24H CNG

Tenaya Therapeutics News

Latest Tenaya Therapeutics Stock News & TNYA Headlines

Download App

People Also Watch

Explore our Tools